Author:
Bauer Michael,Gitlin Michael
Publisher
Springer International Publishing
Reference50 articles.
1. Allen MH, Hirschfeld RM, Wozniak PJ, Baker JD, Bowden CL. Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania. Am J Psychiatry. 2006;163:272–5.
2. Altshuler LL, Calimlim B, McElroy SL, Gitlin MJ, Keck PE Jr, Aquino A, Martens BE, et al. Double-blind comparison of switch rates during lithium monotherapy, sertraline monotherapy and lithium/sertraline combination therapy for the acute treatment of bipolar II depression. Am J Psychiatry. In press.
3. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27(2):596–601.
4. Amsterdam JD, Shults J. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder, a randomized, double-blind, placebo-substitution study. Am J Psychiatry. 2010;167(7):792–800.
5. Armollahi X, Rezaei F, Salehi B, Modabbernia AH, Maroufi A, Esfandiari GR, Naderi M, et al. Double-blind, randomized, placebo-controlled, 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania. J Affect Disord. 2011;129:327–37.